Abstract-Normally, cell cycle progression is tightly coupled to the accumulation of cell mass; however, the mechanisms whereby proliferation and cell growth are linked are poorly understood. We have identified cyclin (Cyc)D2, a G 1 cyclin implicated in mediating S phase entry, as a potential regulator of hypertrophic growth in adult post mitotic myocardium.
D uring development, cell cycle progression is closely coupled to the accumulation of cell mass to maintain a uniform cell size. It has been suggested that proteins involved in cell cycle progression control both processes, thereby linking proliferation and cell growth. 1 In the fetal heart, the proliferative activity of cardiac myocytes is accompanied by increases in cell mass, thereby maintaining myocyte size. However, in adult cardiac myocytes cell growth becomes uncoupled from proliferation after growth stimuli, resulting in hypertrophic growth. 2 The molecular mechanisms by which proliferation and cell growth are coupled in myocytes are poorly understood; however, cell cycle regulatory proteins typically associated with G 1 exit have also been implicated in regulating cardiac myocyte cell growth. [3] [4] [5] Cyclin (Cyc)DCdk4 in particular has been associated with cardiac hypertrophy, although the downstream effectors have not been identified. 6, 7 Previous studies have indicated that inhibiting G 1 cyclin/Cdk activity in adult, postmitotic, cardiac myocytes can attenuate hypertrophic growth. 8, 9 Consistent with this finding, we recently reported that Myc-induced hypertrophic growth was dependent on the presence of CycD2, similar to what has been reported for Myc-induced cell cycle reentry but was independent of Cdk2 activity. 10 The association between CycD and Cdk4 represents the rate-limiting step in a complex cascade that leads to the phosphorylation of a number of proteins, including the retinoblastoma gene product, or Rb. 8, [11] [12] [13] When phosphorylated Rb becomes inactive, its association with a family of transcription factors known as E2Fs is disrupted, thereby allowing them to activate transcription. 14 Previous studies have determined that Rb phosphorylation by CycD-Cdk4 is essential for cell cycle progression, largely by regulating the transcriptional activities of these E2Fs. 15, 16 However, whether this signaling pathway is also important in cardiac hypertrophy is unknown. Among the known hypertrophic signaling cascades, a direct mechanistic link to Rb is perhaps best suggested for its interaction and regulation of the RNA polymerases. 17, 18 Therefore, to understand the role of CycD2 and Rb proteins during cardiac hypertrophy, and to determine the mechanism by which these cell cycle regulators modulate cardiac hypertrophy in vivo, we used mouse models deficient in these proteins. Mice in which CycD2 has been genetically ablated are viable and display normal cardiac anatomy and function. 19 Although normal at baseline, CycD2-deficient mice exhibited attenuated hypertrophy in response to pressure overload. To determine the importance of Rb as a downstream target, we used mice with a cardiac-specific deletion of Rb. These mice have normal heart size at baseline, 20 but hypertrophic growth in response to mechanical or pharmacological stress was increased significantly in Rb-null mice. Furthermore, activity of RNA polymerase (pol) III was increased in Rb-deficient hearts subjected to hemodynamic stress, whereas this transverse aortic constriction (TAC)-induced increased activity was not seen in CycD2
Ϫ/Ϫ myocardium. Thus, we propose that CycD and Rb work in an interdependent manner to control myocyte size in postmitotic myocardium after mechanical stress. Our data identify CycD2, through its phosphorylation target Rb, as a pivotal regulator of RNA pol III activation in myocardial hypertrophy.
Materials and Methods

Animal Studies
Cardiac-restricted Rb-deficient mice (CRb L/L ) have been described. 20 CycD2-deficient mice were a kind gift from Dr P. Sicinski. 19 For TAC, a fixed pressure overload was obtained by surgically constricting the transverse aorta, as described. 21 Genotypes of mice were determined by PCR as described. 10, 20 All animals were handled and maintained in accordance with institutional guidelines and the NIH Guide for the Care and Use of Laboratory Animals.
Isolation of Cardiac Myocytes and Analysis
Neonatal rat ventricular myocytes (NRVMs) were prepared as described. 10, 20 Myocyte dimensions were determined and volumes were calculated using a computerized morphometric system. 21 Details for viral propagation 22 are available in the online data supplement at http://circres.ahajournals.org. For small interfering (si)RNA studies, NRVMs were transfected with 125 nmol/L CycD2 siRNA or nonspecific siRNA (Qiagen) with Lipofectamine 2000 (Invitrogen) according to the specifications of the manufacturer.
Histology and Immunostaining
For histology, hearts were either frozen in OCT compound or fixed overnight in 4% paraformaldehyde buffered with PBS and routinely processed. Details of immunostaining protocols and antibodies are available in the online data supplement.
RNA and Protein Analysis
Total RNA was extracted (Tri Reagent, Sigma) according to the instructions of the manufacturer. Northern blot and ribonucleic protection assays were conducted as previously described. 20, 23 Realtime quantitative PCR was conducted using the ABI PRISM 7700 Sequence Detection System; TaqMan (Applied Biosystems, Foster City, Calif). Primer sequences for all genes analyzed in the present study have been previously reported or are available on request. 23, 24 Western blotting and immunoprecipitations were performed as we have described, 10, 25 and details of the antibodies used are available in the online data supplement.
RNA Pol III Assays
RT-PCR analysis of ARPP P0 mRNA and primary tRNA Tyr or tRNA Leu transcripts was carried out as previously described. 26, 27 Gels were scanned and quantitated by a UVP image analysis system (Adobe PHOTOSHOP 4.0, Adobe Systems, Mountain View, Calif).
Statistical Analysis
All data are presented as meansϮSEM. Results were compared by 1-way ANOVA and Fisher's protected least significant difference or Tukey's multiple comparison post tests, using significance at a probability value of Ͻ0.05.
Results
CycD2-Null Mice Display Attenuated Hypertrophy in Response to Pressure Overload
Our previous work had shown that the hypertrophic effects of Myc were mediated through a CycD2-dependent pathway. 10 In accordance with previous studies, 4 CycD2 protein expression increases both in vitro and in vivo in response to hypertrophic stimuli ( Figure I in the online data supplement). To determine whether the importance of CycD2 was specific to Myc-induced hypertrophy or whether it was more generally important in regulating hypertrophic growth, we subjected CycD2-null mice to pressure overload for 14 days. Homozygous CycD2-deficient mice are viable and appear normal but are sterile. 19 Although not described in the original report, CycD2 Ϫ/Ϫ mice had a 22.5% reduction in body weight compared with wild-type littermates at 12 weeks (supplemental Table I There was a 64% reduction in the hypertrophic response in CycD2-null mice compared with wild-type mice subjected to TAC (PϽ0.02). Two weeks of TAC induced a 25% increase in the HW/BW in CycD2 wild-type mice ( Figure 1C ; HW/BW: 4.35Ϯ0.14 versus 5.45Ϯ0.29 mg/g; PϽ0.005). In contrast, CycD2-null mice displayed an attenuated hypertrophic response with only a 9% increase in HW/BW ( Figure 1C ; HW/BW: 4.40Ϯ0.16 versus 4.81Ϯ0.14 mg/g; PϽ0.05). Fetal cardiac genes including atrial and B-type natriuretic peptides, as well as ␣-skeletal actin, were upregulated in response to TAC in both ventricles from mice of both genotypes despite the differences in myocardial mass, suggesting that not all aspects of the hypertrophic response were impaired ( Figure 1D ).
Rb Regulates Hypertrophic Growth In Vitro
Although several CycD2 phosphorylation targets are present in adult cardiac muscle, Rb is the primary target of CycDCdk4 kinase complexes and has been implicated, at least indirectly, in regulating protein synthesis. 7 Thus, we sought to determine whether phosphorylation of Rb in response to hypertrophic agonists was dependent on CycD2. To knock down CycD2 expression, we transfected NRVMs with either nonspecific siRNA or a specific siRNA to CycD2. As shown in Figure 2A 
Pressure Overload Results in Enhanced Hypertrophy in Adult Rb-Deficient Cardiac Myocytes In Vivo
To determine the role of Rb in regulating the hypertrophic response in adult cardiac myocytes in vivo, we subjected cardiac-restricted Rb-deficient (CRb L/L ) mice we had previously created to TAC. 20 These mice are phenotypically and biochemically normal at baseline. Hearts from Rb-deficient CRb L/L mice were significantly larger than those from control CRb ϩ/ϩ mice after being subjected to 1 week of TAC (supplemental Table II Figure 3A ; PϽ0.05). Although the role of Rb in mediating cell cycle exit in striated muscle is controversial, 28 increased myocyte proliferation cannot explain the increase in cardiac mass that we observed because no evidence of myocyte cell cycle reentry was seen either by 5-bromodeoxyuridine incorporation ( Figure 3B) Figure 3C and 3D), suggesting the increased heart size was related to myocyte hypertrophy. This enhanced hypertrophic response could not be accounted for by extrinsic or intrinsic hemodynamic differences, because the gradient across the constriction at 2 weeks did not differ significantly between the genotypes (51.5Ϯ9.8 versus 60.7Ϯ4.6 mm Hg; PϭNS), and because left ventricular function was normal for both genotypes by 2D echo or invasive hemodynamics. Measurements of contractility (ϩdP/dt; 5003Ϯ862 versus 4243Ϯ313 mm Hg/sec; PϭNS) and relaxation (ϪdP/dt; Ϫ6456Ϯ1329 versus Ϫ5171Ϯ592 mm Hg/sec; PϭNS) were indistinguishable between CRb ϩ/ϩ and CRb L/L mice subjected to TAC for 2 weeks.
To determine whether the exaggerated hypertrophic response to load in Rb-null myocardium was generalizable to other hypertrophic stimuli, we next subjected mice to an infusion of isoproterenol (ISO) versus the vehicle, for one week. ISO 
Expression of E2Fs and E2F Target Genes Is Unchanged in Rb-Deficient Myocardium
Although Rb associates with many proteins, classically it binds and inhibits members of the E2F family of transcription factors. Because E2Fs have been implicated in regulating cardiac hypertrophy, at least in vitro, 29 we examined the expression of E2F family members in CRb ϩ/ϩ or CRb L/L mice at baseline and after TAC with real-time PCR. E2F-1 mRNA increased 3-fold in CRb ϩ/ϩ hearts in response to TAC compared with baseline ( Figure 4A ; 1.00Ϯ0.08 versus 3.05Ϯ0.83; PϽ0.05); however, there were no differences in expression between CRb ϩ/ϩ and CRb L/L mice ( Figure 4A ). Interestingly, no significant change was noted with TAC in the expression of E2F-3, as determined by semiquantitative PCR analysis, which was the E2F family member previously associated with hypertrophic growth in cultured NRVMs ( Figure 4A ). 29 No change in either E2F-4 or -5 expression was seen in response to TAC. Because E2F transcriptional activity could be altered in the absence of Rb, even if expression levels were not, we examined the levels of a panel of E2F-1-dependent target genes. 24 Semiquantitative PCR revealed no significant differences in the expression of any of these E2F-target genes in CRb ϩ/ϩ and CRb L/L myocardium after TAC ( Figure 4B ). Thus, differences in E2F expression or activity are unlikely to account for the enhanced hypertrophic response in Rb-null myocardium.
Pressure Overload Induces Enhanced RNA Pol III Activity in Rb-Null Hearts
RNA pol III activity is known to increase in cardiac myocytes subjected to hypertrophic signals; however, the mechanisms regulating this effect are poorly understood. 30 Rb is known to negatively regulate RNA pol III activity, 17 via binding to Brf-1 and TATA box binding protein (TBP), resulting in inhibition of the pol III-specific transcription factor complex TFIIIB. 25, 31 To clarify the relationship between Rb and these 2 main subunits of TFIIIB, in response to a hypertrophic stimulus, we performed immunoprecipitation studies using total ventricular extracts from wild-type mice exposed to TAC for 7 days. Expression of phosphorylated and total Rb, Brf-1, and TBP in sham and TAC ventricles are displayed in Figure 5A and 5B. Although total expression levels of these factors did not change with TAC, phosphorylation of Rb increased in hypertrophic ventricles ( Figure 5B ). Brf-1 and TBP associated with Rb in wild-type sham ventricles ( Figure  5C ), but phosphorylation of Rb in banded ventricles disrupted this interaction and Rb was no longer associated with Brf-1 and TBP in myocardial lysates from TAC ventricles ( Figure  5C ). To determine the functional significance of the interactions of Rb with these factors, we assayed RNA pol III activity in Rb-deficient hearts. Intron-specific primers were used to assay levels of RNA pol III-specific transcripts from tRNA Tyr or tRNA Leu genes on RNA extracted from ventricles of mice after sham or TAC surgery ( Figure 5D and 5E). RNA pol III activity was similar in sham-operated CRb ϩ/ϩ and CRb L/L myocardium. However, RNA pol III activity was increased in Rb-null hearts after TAC compared with CRb ϩ/ϩ TAC animals ( Figure 5D and 5E). When compared with pressure-overloaded CRb ϩ/ϩ mice, inducible tRNA Tyr transcripts in CRb L/L animals were 40% higher (1.73Ϯ0.17 versus 1.33Ϯ0.24; PϽ0.05), although tRNA Leu transcripts were not elevated significantly (1.52Ϯ0.07 versus 1.22Ϯ0.12; Pϭ0.12). These data are consistent with a model in which Rb is bound to TFIIIB under baseline conditions, but this association is disrupted by hypertrophic stimuli leading to increased RNA pol III activity.
To determine whether the CycD2-Rb interaction that we have proposed has functional significance in hypertrophic myocardium regulating the RNA pol III machinery, we examined the interaction of TBP and Rb in ventricles of CycD2 Ϫ/Ϫ mice ( Figure 6A ). Although the association of TBP and Rb is disrupted by hypertrophic stimuli in CycD2 ϩ/ϩ hearts as expected, TAC did not disrupt the interaction of TBP and Rb in ventricles of CycD2 Ϫ/Ϫ mice ( Figure 6A ). Similarly, both tRNA Tyr and tRNA Leu transcripts were elevated in response to TAC in the CycD2 ϩ/ϩ animal after TAC (Figure 6B and 6C Ϫ/Ϫ mice after TAC.
Discussion
We have previously shown that CycD2 is critical for mediating Myc-induced hypertrophy. 10 In the present study, we examined the role of CycD2 in mediating the hypertrophic response more generally and its possible downstream effectors. Ablation of CycD2 expression resulted in attenuated cardiac hypertrophy in response to pressure overload; conversely, the same mechanical stress led to an exaggerated hypertrophic response in an Rb-null background. This could be explained, at least in part, by the fact that the activity of RNA pol III, which is normally upregulated with hypertrophic stimuli, was further enhanced in the absence of Rb. However, RNA pol III activity remained unchanged in CycD2 Ϫ/Ϫ mice after TAC as compared with wild-type counterparts. These data provide the first direct evidence for a role for the CycD-Rb pathway in regulating cardiac hypertrophy in vivo and provide a rational mechanistic link between the observation by many investigators of the upregulation of G 1 cyclins and increased protein synthesis via activation of RNA polymerase family members.
Hypertrophy was not completely abolished in CycD2
Ϫ/Ϫ mice, and fetal gene induction was unchanged, implying that CycD2 is not the only pathway involved in the development of hypertrophy. This conclusion is consistent with our previous data suggesting that Myc-independent hypertrophic pathways also exist. 10 Thus, although CycD2 may be obligate for Myc-induced hypertrophic growth, separate pathways must regulate Myc induction of fetal genes. The CycD2-Rb pathway would be expected to have a selective effect on the regulation of the translational machinery, and therefore growth (increased protein synthesis) would be more affected than other transcriptional aspects of the hypertrophic response. Because we are proposing that the effects of CycD2-Rb are mediated through RNA pol III, the transcription of genes such as atrial or B-type natriuretic peptides that are controlled by RNA pol II would not be expected to be effected. Our data that CycD is a critical factor in regulating cell size are seemingly at odds with existing data that CycDs are both necessary and sufficient for cardiac cell cycle progression. 32, 33 However, under normal physiological conditions, cell cycle progression is tightly coupled to the accumulation of cell mass (cell growth). 1 Thus, even in situations where CycD2 induces proliferation of cardiac myocytes, it must also be stimulating cell growth because the resultant new myocytes were not smaller in size and CycD2 induced "hypertrophic" growth or increased myocyte size when cell cycle progression was inhibited. 34 These authors concluded that cardiomyocyte hypertrophy is attributable to levels of cell cycle activators unable to overcome the block imposed by cell cycle inhibitors. This conclusion is consistent with studies in Drosophila, which revealed that in undifferentiated proliferating cells, CycD-Cdk4 caused accelerated cell division, whereas in postmitotic cells, CycD-Cdk4 caused cell enlargement. 35 Thus, in the adult mouse heart, in which there is general agreement that CycDs are upregulated with hypertrophic stimuli, clearly the normal physiological consequence is not cell cycle reentry. 36 This does not negate the observation that if expressed at high enough levels CycD2 can overcome the normal restraints to cell cycle reentry that are seen in adult cardiac myocytes. Our results with inducible Myc mice highlight this concept, in which high level activation of Myc induced both hypertrophic growth and cell cycle reentry, although only Ϸ1% of the myocytes reentered the cell cycle. 21 Pocket proteins, and Rb in particular, have a critical role in regulating cardiac cell cycle, 32,37 but little evidence exists directly implicating Rb in cell size control in mammals, although several lines of evidence implicate it in this process. 6 Classically, during cell cycle progression, Rb is inactivated in part by CycD-Cdk4 complexes freeing E2F transcription factors, which then drive cell cycle progression. 15, 16 Although E2F-3 has been implicated in regulating the hypertrophic response, at least in vitro, 29 we were not able to demonstrate differences in the expression or activity of E2F-1 or -3 in Rb-null mice. These data do not rule out a role for E2F family members in regulating cell growth but do question whether they are the primary downstream effectors of the CycD-Rb pathway in cardiac hypertrophy. Given that E2F-1 levels increase with TAC and a number of E2F target genes 24 linked to the control of cell size control were also regulated with TAC, E2Fs may still play a key role in regulating cardiac hypertrophy through a separate pathway.
Interestingly, deletion of CycD2 did not effect the basal cardiac phenotype in CycD2 Ϫ/Ϫ mice as compared with their wild-type counterparts, confirming that significant redundancy exists between CycD isoforms (D1, D2, and D3). 38 However, minor differences were noted in CycD2 mice. Specifically, we noted a reduction in body weight in CycD2 Ϫ/Ϫ animals as compared with wild-type mice, although the HW/BW was normal. Thus, it is likely that other family members can substitute for many but not all functions. Likewise, cardiac-specific deletion of Rb also displayed normal basal cardiac size as compared with CRb ϩ/ϩ mice. In both cases, this is consistent with the observation that basal RNA pol III activity was normal, although RNA pol III activity was augmented after mechanical load elicited in Rb-deficient mice. Rb normally represses pol III transcription by binding pol III transcription factor TFIIIB and sequestering it in an inactive complex. 39 Our findings support a model in which both Brf-1 and TBP (pivotal TFIIIB subunits) become dissociated from Rb in response to a hypertrophic stimulus in vivo. Repression of tRNA and rRNA synthesis may explain the ability of Rb to inhibit protein synthesis and hence hypertrophic growth. 40 Given the critical link between cell cycle progression and cell mass, it is not surprising that mechanisms exist that integrate these 2 modes of growth.
In summary, our results suggest a novel role for the CycD-Rb pathway in the regulation of hypertrophic growth in the adult heart. Future studies to better understand how this novel pathway interacts with other hypertrophic pathways to modulate the translational apparatus should provide insight into how proliferation and cell growth are linked. 
